Ulrike Lueken

Humboldt-Universität zu Berlin
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (16)

Year:

2026

Psychedelic clinical research is expanding rapidly. This review analyses the state and trends in psychedelic clinical trial registrations. A systematic search of ClinicalTrials.Gov was conducted on 11 November 2024, to identify registered interventional trials investigating (therapeutic) effects of serotonergic psychedelics (e.g. lysergic acid diethylamide [LSD], psilocybin, [5-MeO-]DMT). Analyses included a negative binomial regression to assess time trends and descriptive summaries of study characteristics. Outcomes included registration trends, substance distribution, study phase progression, sample and trial characteristics, geographical distribution and psychotherapy reporting. A total of 241 trials were identified, with registrations rising exponentially after 2006 and an acceleration post-2019. Two-thirds of trials are ongoing or planned. Psilocybin remains the most frequently studied substance and is most advanced towards approval, but short-acting psychedelics ([5-MeO-]DMT) have recently been introduced with a more focused clinical scope. Industry involvement is increasing, though university-led research still dominates. Reports of psychotherapy components increased following 2023 FDA recommendations, though no major improvements in intervention descriptions were observed. The rapid expansion of registered psychedelic clinical trials with diverse indications and substances reflects growing clinical interest. While university-led studies initiated early investigations and established a broad knowledge base, later industry involvement increasingly prioritizes scalability and economic considerations by adopting a focused approach towards clinical approval. Inconsistent reporting of psychotherapeutic components limits cross-study comparability and complicates systematic investigations into which combinations of therapeutic elements (type, timing, intensity) may optimize clinical outcomes. Future efforts should focus on complete and standardized trial reporting at study registration to minimize bias, reduce interpretative ambiguity and facilitate cross-trial comparisons.

Year:

2026

Year:

2026

Year:

2026

Introduction Despite the established status of trauma-focused psychotherapy (TFP) as a first-line treatment for post-traumatic stress disorder (PTSD), a substantial proportion of individuals do not achieve clinically significant improvement or discontinue treatment. Exploring augmentation strategies to enhance treatment outcomes is essential to reduce the overall burden PTSD puts on individuals and society. This protocol outlines a systematic review and meta-analysis of randomised controlled trials (RCTs) evaluating the efficacy of non-pharmacological augmentation strategies in addition to TFP for PTSD treatment. Methods and Analysis We comprehensively searched PubMed, Embase, CENTRAL, PTSDpubs, PsycArticles, PsycINFO, PSYNDEX and CINAHL for RCTs without restrictions on publication dates or languages in October 2024. Study screening is currently ongoing. Additionally, we will perform forward and backward searches of the included studies and relevant reviews. Two reviewers will independently screen and select studies, extract data and assess the risk of bias. We will conduct a narrative review to qualitatively synthesise data and a meta-analysis to quantitatively compare the treatment efficacy of augmented TFP with TFP alone or TFP plus placebo. Primary outcomes will be both symptom severity and response rates. The secondary outcome will be dropout rates. We will explore sources of between-study heterogeneity and potential moderators through subgroup and meta-regression analyses. We will assess the overall quality of the included studies with the Grading of Recommendations Assessment, Development, and Evaluation system. Ethics and dissemination Ethical approval is not required. We intend to publish results in a peer-reviewed journal and provide materials and data through the Open Science Framework. PROSPERO registration number CRD42024549435.

Year:

2025

Background Chat-based counseling services are popular for the low-threshold provision of mental health support to youth. In addition, they are particularly suitable for the utilization of natural language processing (NLP) for improved provision of care. Objective Consequently, this paper evaluates the feasibility of such a use case, namely, the NLP-based automated evaluation of satisfaction with the chat interaction. This preregistered approach could be used for evaluation and quality control procedures, as it is particularly relevant for those services. Methods The consultations of 2609 young chatters (around 140,000 messages) and corresponding feedback were used to train and evaluate classifiers to predict whether a chat was perceived as helpful or not. On the one hand, we trained a word vectorizer in combination with an extreme gradient boosting (XGBoost) classifier, applying cross-validation and extensive hyperparameter tuning. On the other hand, we trained several transformer-based models, comparing model types, preprocessing, and over- and undersampling techniques. For both model types, we selected the best-performing approach on the training set for a final performance evaluation on the 522 users in the final test set. Results The fine-tuned XGBoost classifier achieved an area under the receiver operating characteristic score of 0.69 (P<.001), as well as a Matthews correlation coefficient of 0.25 on the previously unseen test set. The selected Longformer-based model did not outperform this baseline, scoring 0.68 (P=.69). A Shapley additive explanations explainability approach suggested that help seekers rating a consultation as helpful commonly expressed their satisfaction already within the conversation. In contrast, the rejection of offered exercises predicted perceived unhelpfulness. Conclusions Chat conversations include relevant information regarding the perceived quality of an interaction that can be used by NLP-based prediction approaches. However, to determine if the moderate predictive performance translates into meaningful service improvements requires randomized trials. Further, our results highlight the relevance of contrasting pretrained models with simpler baselines to avoid the implementation of unnecessarily complex models. Trial Registration Open Science Framework SR4Q9; https://osf.io/sr4q9

Year:

2025

Pavlovian fear conditioning is a fundamental process in both health and disease. We investigated its neural correlates and sources of variability using harmonized functional magnetic resonance imaging data from 2,199 individuals across nine countries, including 1,888 healthy individuals and 311 with anxiety-related or depressive disorders. Using mega-analysis and normative modelling, we show that fear conditioning consistently engages brain regions within the "central autonomic–interoceptive" or "salience" network. Several task variables strongly modulate activity in these regions, contributing to variability in neural responses. Additionally, brain activation patterns differ between healthy individuals and those with anxiety-related or depressive disorders, with distinct profiles characterizing specific disorders such as post-traumatic stress disorder and obsessive-compulsive disorder. While the neural correlates of fear conditioning are highly generalizable at the population level, variability arises from differences in task design and clinical status, highlighting the importance of methodological diversity in capturing fear learning mechanisms.

Year:

2025

Negative affect (NA)—encompassing heightened states of sadness, anxiety, and guilt—is a key symptom across a spectrum of internalizing disorders. Recent advancements in digital phenotyping (DP) and machine learning (ML) have raised hopes of automatically identifying short-term fluctuations in NA through digital phenotyping, a prerequisite for Just-In-Time Adaptive Interventions (JITAI). But evidence on the short-term prediction of NA states with passive DP data is sparse. In this preregistered study, we examined whether passive sensor data (heart rate, step count, GPS) and contextual information could predict short-term changes in NA in a sample of 158 outpatients with internalizing disorders. We systematically compared personalized ML approaches (i.e. mixed effect random forests) to population-based models (e.g., random forests) and two benchmark models (individual and population based average NA). We found that personalized ML approaches yielded substantial performance gains compared to population-based models. Nonetheless, the best models only marginally outperformed the benchmark predicting average NA per person. Our findings question the feasibility of detecting short term changes in NA based on completely passively collected sensor data. Future efforts could incorporate richer and/or more raw data streams or test sequential modelling approaches. This will help clarify whether DP and personalized ML can reliably deliver just-in-time, data-driven support for individuals with internalizing disorders.

Year:

2025

Chat-based counseling hotlines emerged as a promising low-threshold intervention for youth mental health. However, despite the resulting availability of large text corpora, little work has investigated Natural Language Processing (NLP) applications within this setting. Therefore, this preregistered approach (OSF: XA4PN) utilizes a sample of approximately 19,000 children and young adults that received a chat consultation from a 24/7 crisis service in Germany. Around 800,000 messages were used to predict whether chatters would contact the service again, as this would allow the provision of or redirection to additional treatment. We trained an XGBoost Classifier on the words of the anonymized conversations, using repeated cross-validation and bayesian optimization for hyperparameter search. The best model was able to achieve an AUROC score of 0.68 ( p < 0.01) on the previously unseen 3942 newest consultations. A shapely-based explainability approach revealed that words indicating younger age or female gender and terms related to self-harm and suicidal thoughts were associated with a higher chance of recontacting. We conclude that NLP-based predictions of recurrent contact are a promising path toward personalized care at chat hotlines.

Year:

2024

Theoretical Background: Increased mental health distress in children and families during the COVID-19 pandemic has been widely reported in studies. Aim: During the first year of the COVID-19 pandemic (i. e., 2020 – 2021), we examined a help-seeking sample for child distress and the associations with parent distress, quality of life, and COVID-19-specific factors, aiming to describe families seeking help. Method: We conducted an online survey in help-seeking families ( N = 169, children aged 5 – 17 years). Results: Children’s anxiety and depression did not exceed clinical cutoffs but quality of life did. Only parental and child depressiveness were related. Child emotion regulation was shown to be the only relevant predictor of child anxiety, depressive symptoms, and quality of life, whereas no parental or COVID-19-related factors reached significance. Discussion and Conclusion: Specifics of our help-seeking sample differed from other COVID-19 studies, highlighting the relevance of taking a closer look at specific samples to provide custom-fit support.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (50)

Henrik Walter

Charité - Universitätsmedizin Berlin

GERMANY
View details

Katja Koelkebeck

Professor, Senior psychiatrist

Bielefeld University, Medical School and University Medical Center OWL

GERMANY
View details

Renee Visser

Academic, Assistant Professor

University of Amsterdam

NETHERLANDS
View details

Christine Knaevelsrud

Freie Universität Berlin

GERMANY
View details

Carien M. van Reekum

University of Reading

UNITED KINGDOM
View details

Jayne Morriss

University of Southampton

UNITED KINGDOM
View details

Kevin Hilbert

Professor

Health and Medical University Erfurt

GERMANY
View details

Katie McLaughlin

Professor of Psychology

Harvard University

UNITED STATES
View details

Joscha Böhnlein

Teaching Psychotherapist

University of Münster

GERMANY
View details

Norbert Kathmann

Professor

Humboldt-Universität zu Berlin

GERMANY
View details

Andre Pittig

University of Göttingen

GERMANY
View details

Christian J. Merz

Ruhr-Universität Bochum

GERMANY
View details

Miguel Fullana

Consultant Clinical Psychologist/Senior Researcher

Hospital Clínic de Barcelona

SPAIN
View details

Annette Brose

Max Planck Institute for Human Development

GERMANY
View details

Markus Junghoefer

Professor

Westfälische Wilhelms-Universität Münster

GERMANY
View details

Manuel Kuhn

Senior Researcher

Charité - Universitätsmedizin Berlin

GERMANY
View details

Steven Greening

Associate Professor

University of Manitoba

CANADA
View details

Andreas Reif

Chair

Goethe University Frankfurt

GERMANY
View details

Jonathan Repple

Professor and senior managing physician

University Hospital Frankfurt

GERMANY
View details

Fredrik Åhs

Associate Professor at Mid Sweden University

Mid Sweden University

SWEDEN
View details

Nynke A Groenewold

Associate Professor

University of Cape Town

SOUTH AFRICA
View details

Marta Cano

Ramón y Cajal Researcher – Head of the Imaging for Precision Psychiatry Research Line

Institut de Recerca Sant Pau

SPAIN
View details

Samuel Cooper

Assistant Professor

University of Texas at Austin

UNITED STATES
View details

Janna Marie Bas-Hoogendam

Assistant professor

Leiden University

NETHERLANDS
View details

Julia Asbrand

Professor

Friedrich Schiller University Jena

GERMANY
View details

Udo Dannlowski

University of Münster

GERMANY
View details

Andreas Keil

Distinguished Professor

University of Florida

UNITED STATES
View details

Drin Ferizaj

Charité - Universitätsmedizin Berlin

GERMANY
View details

Martin Ulrich

Ulm University

GERMANY
View details

Tilo Kircher

Professor, Chair

University of Marburg

GERMANY
View details

Marcel Romanos

Head of department

Universitätsklinikum Würzburg

GERMANY
View details

Jan Richter

University of Hildesheim

GERMANY
View details

Daphne J. Holt

Director, Resilience and Prevention Program; Co-Director, Psychosis Clinical and Research Program; Associate Professor, Harvard Medical School

Massachusetts General Hospital

UNITED STATES
View details

Christine Larson

Professor

University of Wisconsin-Milwaukee

UNITED STATES
View details

Winfried Rief

Professor of Clinical Psychology

University of Marburg

GERMANY
View details

Matthias Gamer

Professor for Experimental Clinical Psychology

Julius-Maximilians-Universität Würzburg

GERMANY
View details

Xi Zhu

Assistant Professor

Columbia University Irving Medical Center

UNITED STATES
View details

Martin J Herrmann

University Hospital Würzburg

GERMANY
View details

Joaquim Radua

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN
View details

Benjamin Straube

Professor for Translational Neuroimaging

Philipps-Universität Marburg

GERMANY
View details

M. Lotze

University of Greifswald

GERMANY
View details

Kerstin Ritter (née Hackmack)

Junior professor for Computational Neuroscience

Charité - Universitätsmedizin Berlin

GERMANY
View details

Dan Stein

Professor and Chair of Psychiatry

University of Cape Town

SOUTH AFRICA
View details

Ashley A Huggins

Assistant Professor

University of Arizona

UNITED STATES
View details

Tina Lonsdorf

Professorin

Bielefeld University

GERMANY
View details

Joseph Dunsmoor

University of Texas at Austin

UNITED STATES
View details

Babette Renneberg

Professor

Freie Universität Berlin

GERMANY
View details

Miriam Schiele

Full Professor and Chair

Technische Universität Dresden

GERMANY
View details

Tom Beckers

Professor of Psychology

KU Leuven

BELGIUM
View details

Dominik R. Bach

Hertz Chair for Artificial Intelligence and Neuroscience

University of Bonn

GERMANY
View details